Bitcoin(BTC/USD) Daily Chart Analysis For Week of Sep 6, 2024Technical Analysis and Outlook:
The recent market activity witnessed a continued decline in the value of Bitcoin, leading to a significant drop and triggering a shift to our designated Key Support level of 54000. Current market sentiment indicates a potential recovery towards Mean Resistance 56700, possibly extending to Mean Resistance 59200. It is pertinent to acknowledge that persistent selling pressure at this stage could precipitate a further down towards the previously completed Interim Coin Dip 50000 before a resurgence occurs.
Investing
NOC vs LMT: A Valuation War Between Top Defence Manufacturers!ABOUT COMPANIES
Northrop Grumman NYSE:NOC excels in advanced aircraft systems, divided into four main areas: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. Aeronautics Systems designs and manufactures cutting-edge aircraft for the U.S. military and global clients. Defense Systems integrates battle management and weaponry, while Mission Systems delivers innovative solutions for defense and intelligence. Space Systems focuses on solutions for national security and commercial purposes. Established in 1939 by John K. Northrop and others, the company is headquartered in Falls Church, VA.
Lockheed Martin NYSE:LMT stands as a top global security and aerospace company, dedicated to the research, design, and production of advanced technology systems. It operates in four primary segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment focuses on military aircraft, including combat and drones. MFC specializes in air and missile defense and precision strike systems. RMS develops military and commercial helicopters and cyber solutions, while the Space segment creates satellites and defense systems. Founded in 1912, the company is located in Bethesda, MD.
MARKET CAPITALIZATION
● Northrop Grumman (NYSE: NOC) - $75.96 Billion
● Lockheed Martin (NYSE: LMT) - $135.53 Billion
TECHNICAL ASPECTS
● Northrop Grumman
➖ The monthly chart shows that the stock price is currently on a distinct upward path.
➖ Previously, it faced resistance around the $360 level, caused a notable pullback.
➖ Subsequently, the price formed a Double Bottom pattern and broke out successfully.
➖ This breakout drove the price to an all-time high near the $556 level but the price started declining from there.
➖ Nevertheless, the stock price found strong support around the $420 level, allowed it to bounce back.
➖ Currently, the stock is approaching its previous all-time high, and if it can overcome that resistance, we can anticipate further price increases in the coming days.
● Lockheed Martin
➖ This stock is on a strong upward trajectory, consistently achieving higher highs and higher lows.
➖ Following a significant breakout around the $500 mark, the stock price surged and is now trading at $568.5, just shy of its all-time peak of $578.7.
➖ From a technical perspective, the price is hovering just below the upper boundary of a parallel channel, which may act as a resistance point.
➖ However, if the price can break through this range and maintain that momentum, we could see even greater upward movement ahead.
Relative Strength
● The chart shows that the NYSE Composite TVC:NYA has provided a solid return on investment of about 18% in the last year. In comparison, Northrop Grumman and Lockheed Martin have done even better, with returns of around 20% and 27%, respectively.
REVENUE BREAKDOWN
● Northrop Grumman
The company derives its income from four main segments.
➖ The largest share comes from the space systems segment, contributing around 33%, which equates to $14.34 billion out of a total revenue of $43 billion.
➖ Next, the aeronautics systems segment adds nearly 27%, bringing in $11.61 billion of the overall revenue.
➖ The mission systems segment follows closely, accounting for about 26%, or $11.12 billion of the total.
➖ Finally, the defense systems segment generates nearly 14%, totaling $5.99 billion of the overall revenue.
● Lockheed Martin
Similar to Northrop Grumman, this company also operates through four segments to drive its revenue.
➖ The aeronautics segment leads the way, contributing around 38.4%, which amounts to nearly $28.77 billion of the total revenue of $74.85 billion.
➖ The rotary and mission systems segment accounts for 26.4% of revenue, equating to $19.76 billion.
➖ Next, the space segment contributes 17.8%, which is $13.33 billion.
➖ Finally, the missile and fire control segment makes up 17.4%, totaling $12.99 billion of the overall revenue.
REVENUE & PROFIT ANALYSIS
● Northrop Grumman
Revenue
➖ For the FY23 the revenue has jumped by 7.3% to $39.3 B from $36.6 B in FY22.
➖ In the recent June quarter there is no significant surge in revenue as the recent quarterly revenue stands at $10.2 B compared to $10.1 B in the march 2024. But from the last year June quarter the revenue has grown by almost 6% from $9.6 B.
Profit
➖ The operating profit has experienced a decline, with FY23 reporting only $2.9 billion, a drop from $6.3 billion in FY22.
➖ In the latest June quarter, the operating profit held steady at $1.3 billion, unchanged from the March quarter.
Basic EPS (LTM)
➖ The basic EPS saw a slight rise in June, climbing to $15.26 (LTM) from $14.33 (LTM) in March 2024. However, compared to the same quarter last year, there has been a significant drop from $30.23 (LTM)
Analyzing these numbers shows that although revenue has risen, the company is having difficulty producing profits, which may impact the share price in the near term.
● Lockheed Martin
Revenue
➖ In FY23, the company experienced a slight revenue increase of 2.4%, rising to $67.6 billion from $66 billion in FY22.
➖ During the recent June quarter, revenue reached $18.1 billion, up from $17.2 billion in the March quarter. Compared to the same quarter last year, this represents a significant growth of approximately 8.6%, up from $16.7 billion.
Profit
➖ The operating income has experienced a year-over-year increase. For FY23, it reached $9.0 billion, marking a 23% rise from $7.3 billion in FY22.
➖ However, there hasn't been a notable change in operating profit on a quarter-over-quarter basis. In June, the operating profit stood at $2.2 billion, slightly up from $2.1 billion in March. This figure is consistent with the operating profit reported in the same quarter last year.
Basic EPS (LTM)
➖ The basic EPS stood at $27.58 (LTM) in June 2024
➖ Over the past year, there has been no notable growth in EPS (LTM)
Lockheed Martin demonstrates a more robust financial standing compared to Northman Grumman.
VALUATION
● P/E Ratio
➖ P/E vs. Median P/E
(1) Northrop Grumman's current price-to-earnings ratio over the past twelve months stands at 33.2x, which appears elevated when compared to its four-year median of 15.2x.
(2) Lockheed Martin's recent twelve-month p/e ratio is 20.1x, also showing a rise relative to its four-year median of 16.2x.
➖ P/E vs. Industry P/E
(1) NOC shows a fair valuation with a Price-To-Earnings Ratio of 33.2x, which is just below the US Aerospace & Defense Industry average of 33.3x.
(2) On the other hand, LMT, with a P/E of 20.1x, seems to be undervalued relative to the industry average of 33.3x.
● P/B Ratio
➖ NOC's current P/B ratio of 5.3x appears inflated when stacked against the US Aerospace & Defense Industry average of 3.2x.
➖ In the case of LMT, it stands out as significantly overvalued, boasting a P/B ratio of 21.9x, which is far above the industry average of 3.2x.
FREE CASH FLOW ANALYSIS
● Northrop Grumman
➖ In FY23, cash flow from operations saw a remarkable increase, climbing to $3.9 billion, a notable rise from $2.9 billion in FY22.
➖ In the most recent quarter, this figure reached $4.4 billion, up from $3.9 billion in March.
● Lockheed Martin
➖ There was little change in operating cash flow, with FY23 reporting $7.9 billion, which is nearly the same as the $7.8 billion recorded in FY22.
➖ On a quarterly basis, there has been an uptick; for the June quarter, operating cash flow stood at $8.8 billion, an increase from $8.0 billion in March and $7.7 billion in the same quarter last year.
DEBT ANALYSIS
● NOC currently has a debt of $16.3 billion, resulting in a debt-to-equity ratio of 114%. While this may raise some concerns, the company boasts an interest coverage ratio of 5.2, indicating a solid ability to manage interest payments on its debt.
● In contrast, LMT carries a debt of $19.3 billion, leading to a debt-to-equity ratio of 311%, which suggests poor financial health. However, with an impressive interest coverage ratio of 8.9, the company is in a strong position to meet its interest obligations.
TOP SHAREHOLDERS
● Northrop Grumman
➖ State Street Global has a notable 9.59% ownership in this firm, while The Vanguard Group possesses a considerable 8.22% stake.
● Lockheed Martin
➖ In addition to the 11.2% held by Lockheed Martin's Employee Stock Ownership Plan (ESOP), State Street Global and The Vanguard Group own 15.1% and 8.99% respectively.
➖ BlackRock also maintains a significant 7.13% interest in this company.
CONCLUSION
After reviewing all the financial metrics, it becomes evident that each company possesses distinct strengths and weaknesses. It's difficult to determine which one is the superior investment choice at this moment. A look at the monthly chart indicates that both companies are currently at a high point, but they could be good candidates for accumulation during any significant downturns.
In 2023, the US spent $916 billion on defense, which was more than any other country. This was an increase of $55 billion from 2022. and this figure could increase given the current global landscape. Therefore, companies like Northrop Grumman and Lockheed Martin are expected to perform well in the foreseeable future.
Deutsche Bank (DBK): A Perfect Reversal?Our analysis on Deutsche Bank (DBK) dates back to June, but we've continued to monitor the stock closely for you. We saw that DBK respected the last possible level within our targeted area, which was aligned with the level of Wave 1. Typically, for a Wave 4, we don't want to see the asset linger too long in this area, but in the case of DBK, it only dipped into it briefly before reversing, showing a strong and positive reaction.
We now anticipate a surge above the Wave 3 level, which would also push the stock above the trend channel. Such a conclusion to this cycle would be a very bullish sign, likely leading to a deeper pullback in the overarching Wave (2). At that point, we would definitely consider buying shares as the setup looks promising for long-term gains.
Meta (META): Watching for a SetbackIt has been a lovely rise within META since 2023. However, we are now continuing to range for some time, which is usually a sign of a possible setback before a continuation. This setback could be beneficial for sustainable growth and further rises.
Zooming in, we can observe a range building since February 2024. This range has been respected multiple times so far, and it seems likely to continue. However, the small breach of the top looks somewhat like a Swing Failure Pattern (SFP) and could be a signal of profit-taking by many traders. If we breach through the $440 level, we could see a change of structure if a candle closes below it. If this happens, it would confirm our analysis. Until then, we might see higher prices as this is technically still a bullish trend within this range.
Another small indicator supporting our view is the bearish divergence on the RSI. While RSI is a good indicator with a high win rate, it’s not infallible, so this scenario might not play out. Still, this seems the most likely outcome to us at the moment.
UCAL - 6 YEARS OF "W" PATTERN BREAKOUT6 Years of "W" Pattern Breakout breakout
BUY PRICE : 190
SL : 150 (only for swing traders)
TARGET : 250, 330 (72%)
Disclaimer - All information on this page is for educational purposes only,
we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made.
PLASTIBLENDS - ROUND BOTTOM BREAKOUT8 Months of Round Bottom breakout
BUY PRICE : 353
SL : 304 (only for swing traders)
TARGET : 480 (36%)
Disclaimer - All information on this page is for educational purposes only,
we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made.
SEQUENT SCIENTIFIC - Multi Year Breakout StockINVERSE HEAD & SHOULDER PATTERN BREAKOUT STOCK FOR SWING TRADING
> 2 Years of Inverse head & shoulder breakout
BUY PRICE : 155
SL : 125 (only for swing traders)
TARGET : 202, 250, 305 (100%)
Disclaimer - All information on this page is for educational purposes only,
we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made.
S&P 500 Daily Chart Analysis For Week of Aug 30, 2024Technical Analysis and Outlook:
Throughout the current week's trading sessions, the S&P 500 Index has exhibited notable fluctuations, initially reaching the Mean Support level of 5570 and subsequently demonstrating resilience by rebounding toward the specified targets outlined in the preceding weekly analysis, encompassing the completed Inner Index Rally at 5666 and Key Resistance level at 5667. Beyond those targets, the focus is on attaining the extended rebound targets, specifically the next Inner Index Rally at 5745 and the long-awaited Outer Index Rally at 5840. It is essential to recognize that achieving these targets will likely prompt a selling price action.
EUR/USD Daily Chart Analysis For Week of Aug 30, 2024Technical Analysis and Outlook:
Throughout the current week's trading session, the Eurodollar has demonstrated significant downward momentum after retesting the pivotal completed Inner Currency Rally at 1.120. The resultant downward trend has effectively suppressed our Mean Support at 1.111 and currently encounters selling pressure at the present level, potentially driving the price down to our designated support levels of 1.102 and 1.097. Nevertheless, the possibility exists of transient buying pressure, which will cause a push in price to Mean Resistance at 1.109 in the interim price action.
Bitcoin(BTC/USD) Daily Chart Analysis For Week of Aug 30, 2024Technical Analysis and Outlook:
The "Primary Squeeze" of Bitcoin has experienced a significant drop to our Mean Support levels at 62700 and 60300, and it currently hovers just above the critical Mean Support level at 57600. Currently, the cryptocurrency is positioned for further upward movement, with the primary target being a retest of the completed Interim Coin Rally marked at 64900. It is noteworthy that the selling pressure at this level may lead to a decline in the coin's price towards the Key Support level at 54000.
$ETH WEEKLY UPDATE CONFIRMATIONS & INVEST SETUPCRYPTOCAP:ETH will dump more if it breaks 2300 & 1950 support!
I already shared 1 day trade setup, checkout here :
Next Weekly strong support at $1620 & $1130
For Long term investment you can DCA at weekly support & Target : $3.2k-4.5k-$6k
#DYOR
Weekly confirmations are -
- Inverse HnS
- Previous ATH (2017)
- Volume profile
- 3 drive pattern
- Monthly 100 EMA Support
IF YOU LIKE THIS UPDATE PLEASE BOOST & FOLLOW. THANKS
Concerned about aging? Start investing in Addus now!The aging U.S. population is set to double by 2050, increasing the need for caregivers. Addus HomeCare Corporation, based in Frisco, Texas, provides essential personal care, hospice, and home health services. With a market cap of $2.35 billion, Addus reported $1.115 billion in revenue in June 2024, with a 27% profit increase. The company is debt-free and has major shareholders like Blackrock and The Vanguard Group. EPS is forecasted to grow significantly by December 2025. With a growing need for home healthcare services, the company is well-positioned to expand its customer base and market presence.
Company Overview
Addus HomeCare Corporation and its subsidiaries offer personal care services for the elderly, disabled, and those at risk of hospitalization in the U.S. It operates in three areas: Personal Care, Hospice, and Home Health. The Personal Care segment helps with daily activities like bathing, grooming, and meal preparation. The Hospice segment provides care and support for terminally ill patients and their families. The Home Health segment delivers skilled nursing and therapy services for those recovering from illness or hospitalization. Its clients include government agencies, managed care organizations, insurers, and private individuals. Founded in 1979, Addus is based in Frisco, Texas.
Investment Advice by Naranj Capital
Buy Addus Homecare Corporation
NASDAQ:ADUS
● Buy Range- 120 - 125
● Target- 150 - 160
● Potential Return- 25-30%
● Duration- 10 -12 Months
Market Capitalization - $ 2.35B
Sector - Healthcare (Nursing)
Technical Analysis
● The monthly chart indicates a clear upward trend in prices.
● Earlier, the stock peaked near the 129 (128.8 to be precise) level before experiencing a correction, which was subsequently followed by an elongated consolidation period from November 2020 to July 2024.
● Recently, the stock has successfully made a multi-year breakout of the previous resistance zone and has maintained its position above this breakout level.
● We expect this momentum to persist, leading to further price increases in the days ahead.
Entry, Exit & Stop-loss
● Entry with Capital allocation strategy
(1) consider adding 50% of your desired quantity at the current market price (132 - 133).
(2) The second buying opportunity will be in the 120 - 122 range, where you can also add rest 50% of your quantity.
● Target
Chart analysis indicates a promising upside potential of 25-30% for this stock from the best buying level, with a target around the 155 to 160. There is also a strong likelihood that the stock could exceed this target.
● Stoploss
It is crucial to implement a strict stop-loss below the 115 level, as we anticipate that the stock may encounter challenges if it drops to this point.
Revenue Breakdown
The company generates its revenue through three primary segments.
(1) The personal care sector represents around 74.2% of the overall revenue, totaling $827 million out of $1.11 billion.
(2) Meanwhile, hospice services contribute nearly 19.7%, amounting to $219.8 million of the total revenue.
(3) The home health segment accounts for approximately 6.1%, which translates to $67.8 million of the overall revenue.
Sales & Profit Analysis
● A noticeable rise in revenue has been observed. For the June quarter, revenue reached $1.115 billion, marking an 11.6% increase from $999 million in June 2023 (YoY) and a 2.5% rise from $1.08 billion in March 2024 (QoQ).
● Additionally, profits surged by 27% in the latest quarter, climbing to $68.89 million from $53.83 million in the same quarter last year, and up 5% from $65.67 million in March 2024.
● The profit margin has also improved, increasing from 5.4% to 6.2% year-on-year.
● The basic EPS for the June 2024 quarter is reported at 4.28, marking a significant increase of 27% from 3.37 in the same quarter last year.
Peer Companies
(1) Privia Health Group (NASDAQ: PRVA) - $ 2.41B NASDAQ:PRVA
(2) Amedisys (NASDAQ: AMED) - $ 3.21B NASDAQ:AMED
(3) Astrana Health (NASDAQ: ASTH) - $ 2.33B NASDAQ:ASTH
Valuation
● P/E vs Fair P/E Ratio
➖ The current PE ratio stands at 34.1x, slightly expensive to the estimated Fair PE of 28.7x.
● P/E Ratio vs Peers
➖ ADUS offers great value with a Price-To-Earnings Ratio of 34.1x, significantly lower than the peer average of 62.7x.
● P/E Ratio vs Industry P/E
➖ ADUS seems to come at a higher price, boasting a Price-To-Earnings Ratio of 34.1x, notably surpassing the US Healthcare industry average of 26.2x.
Debt Analysis
➖ ADUS stands proudly as a debt-free entity, a remarkable transformation from five years ago when its debt to equity ratio stood at 12.9%. This significant shift underscores the company's commitment to financial health and stability.
Top Shareholders
● Blackrock currently holds a substantial 16% stake in this stock, reflecting an impressive increase of 11.2% since the March quarter.
● Meanwhile, The Vanguard Group has also boosted its investment, raising its stake by 8.5% from the previous quarter, bringing their total holding to 7.74%.
Earnings per Share Growth Forecasts
Experts forecast that the earnings per share (EPS) could increase from $4.28 to $4.51 by December 2024, and further rise to $5.03 by December 2025.
Conclusion
With the growing need for home healthcare services, the company is well-positioned to broaden its customer base and enhance its market presence.
Sapphire (K.F.C & Pizza Hut) Showing Good Structural Breakout NSE:SAPPHIRE
.............................................
Company has delivered good profit growth of 26.0% CAGR over last 5 years.
.............................................
FY24 Highlights
• Sapphire has delivered the best all-round
performance in the QSR industry (all parameters considered):
Revenue scale & growth ,
Adj. EBITDA margin & growth
and New restaurant additions .
• Sapphire KFC delivered highest ever annual
restaurant EBITDA margin %: 19.7% .
• Sapphire KFC and Pizza Hut being recognized
as among the top 3 franchisees of Yum
globally on customer metrics and operating
standards.
• Sapphire Foods is ranked No.1 QSR in India
and at 95th percentile amongst QSR globally on
Dow Jones Sustainability Index (DJSI).
• We achieved our best ever employee
engagement score since inception and placed
at 88th percentile amongst all companies
surveyed worldwide by Gallup.
.............................................
RUNE - BIG GAIN (BIG PICTURE)Dear friends,
I will show another coin next to the LINK where I see Elliot wave expressed.. For LINKCHAIN, you have an analysis below this post..
First I would like to show my old projections related to RUNE and the exact take profit and return to DCA on it..
Here is a projection of profit taking.. and an accurately expressed mass jump of the first wave..
Then marked zones for returning to the market.
Now that all that has happened, I have scenario A and B. The first scenario is that the bottom is behind us and that the first purchase is an excellent decision, on the other hand, we also have plan B because there is great resistance at $5.
If the price does not show strength, the last buying target would be 2.2. Below that there is a very large volume and below that the door opens for a big risk (FOR NOW I'M VERY BULLISH)
The first target will be scalar from $30 and on.
This will all happen only if BTC manages to break the ATH
ALTLAYER with BTC pair (investing chart)hello dear trader and investors
About Altlayer :
AltLayer is an open and decentralized protocol for rollups. AltLayer brings together a novel idea of Restaked Rollups which takes rollups (spun from any rollup stack such as OP Stack, Arbitrum Orbit, Polygon CDK, ZK Stack, etc.) and provides them with enhanced security, decentralization, interoperability and crypto-economic fast finality by leveraging restaking mechanism.
ALT is AltLayer's native utility token and is used in the following functions:
Economic bond: ALT token will be used alongside restaked assets to provide economic stake. This stake can be slashed if a malicious behavior is detected.
Governance: ALT token holders can vote on governance decisions.
Protocol Incentivization: Operators in the AltLayer ecosystem can earn ALT tokens as rewards for their services.
Protocol Fees: Network participants will need to pay for intra-network services in ALT tokens.
AltLayer’s core offering of restaked rollups consists of three key products:
VITAL: An Actively Validated Service (AVS), where operators verify blocks and the corresponding states committed by the rollup sequencer and raise fraud proof challenges if necessary.
MACH: A protocol to provide faster finality to rollups by allowing operators to restake Ethereum-based assets to back any claims on the rollup state.
SQUAD: Offer decentralized sequencing with economic backing. Decentralized sequencing eliminates short-term liveness concerns, bad MEV, rent extractions and other issues associated with rollups that operate with a single sequencer.
AltLayer has raised 22.8MM USD from two rounds of private token sales, where 18.50% of the ALT total token supply has been sold at 0.008 USD / ALT and 0.018 USD / ALT respectively.
AltLayer’s investors include Polychain Capital, Binance Labs, Jump Crypto, Breyer Capital, DAO5, Balaji Srinivasan (former CTO of Coinbase and former GP of a16z), Gavin Wood (Co-Founder of Ethereum and Parity), Sean Neville (Circle Co-Founder and USDC architect) and Ryan Selkis (Founder of Messari), among others.
As of January 17th 2024, the total supply of ALT is 10,000,000,000 and the circulating supply upon listing will be 1,100,000,000 (11.00% of the total token supply.)
Cup And Handle formation in Marksans Pharma on Monthly CandlesA Cup and Handle Pattern seems to be forming in Marksans Pharma on Monthly basis which explains the recent up move.
Good Buying Price would be at 166 (If Someone has bought it at this price can hold it)
Other Buying Opportunity can be Below 260
SL can be marked at 106
Targets Can be
Target 1 can be around 290 to 300
Target 2 can be around 390 to 400
Caution: This is not a stock trading Advice or Tip, it's just for learning purposes I am not a professional trader or a SEBI registered advisor. Please don't consider this as an advice and make your own analysis before investing.
Thankyou!
NETWORK 18 - RANGE BREAKOUT FOR SWINGRANGE BREAKOUT FOR SWING TRADING
NEW BUY PRICE : 95
SL : 85 (only for swing traders)
TARGET : 120, 135 (40%)
Disclaimer - All information on this page is for educational purposes only, we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made.
AEROFLEX IND - INVERSE HEAD & SHOULDER PATTERN BREAKOUT INVERSE HEAD & SHOULDER PATTERN BREAKOUT STOCK FOR SWING TRADING
BUY PRICE : 174
SL : 158 (only for swing traders)
TARGET : 196, 230 (32%)
Disclaimer - All information on this page is for educational purposes only,
we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made.